http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105087810-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105087810-B |
titleOfInvention | Application of the miRNA-C compounds in the clinical diagnosis marker and medicine of chronic pain disorders is prepared |
abstract | The invention discloses miRNA C compounds to prepare chronic pain disorders clinical diagnosis marker and prepare the application in treating chronic ache medicine.The present invention is screened by many experiments, test result indicates that, miRNA C express downward in chronic arthritic pain model and chronic pain patient blood, chronic ache generation and formation can be significantly inhibited by raising miRNA C, quantitative analysis further has been carried out to the blood clinical sample of chronic pain patient, has shown the marker that miRNA C can occur as chronic ache. |
priorityDate | 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.